Modulating effect of ginseng saponins on heterologously expressed HERG currents in Xenopus oocytes

Acta Pharmacologica Sinica

Volumn 26, Issue 5, 2005, Pages 551-558

  Kim, Cuk Seong ^a   Son, Sook Jin ^a   Kim, Hyo Shin ^a   Kim, Yong Duk ^a   Lee, Kyu Seung ^a   Jeon, Byeong Hwa ^a   Kim, Kwang Jin ^a   Park, Jin Kyu ^b   Park, Jin Bong ^a  

^a Chungnam National University   (South Korea)

^b Korea Ginseng Corporation   (South Korea)

Author keywords

Action potentials; Ginseng saponins; Patch clamp techniques; Potassium channels; Xenopus laevis

Indexed keywords

GINSENG EXTRACT; GINSENG SAPONIN; GINSENOSIDE; INWARDLY RECTIFYING POTASSIUM CHANNEL; PANAXIDIOL; PANAXITRIOL; POTASSIUM CHANNEL HERG; SAPONIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; HEART MUSCLE POTENTIAL; NONHUMAN; OOCYTE; POTASSIUM CURRENT; PROTEIN EXPRESSION; REPERFUSION INJURY; VOLTAGE CLAMP; XENOPUS;

ACTION POTENTIALS; ANIMALS; GINSENOSIDES; OOCYTES; PANAX; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS, VOLTAGE-GATED; XENOPUS LAEVIS;

EID: 18744412989     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2005.00116.x     Document Type: Article

References (32)

1. Chen X. Cardiovascular protection by ginsenosides and their nitric oxide releasing action. Clin Exp Pharmacol Physiol 1996; 23: 728-32.
2. Zhang JM, Matsuura Y, Sueda T, Orihashi K. Beneficial effects of ginsenosides of stems and leaves on cardiac and coronary vascular functions after 12-hour rat heart preservation. Transplant Proc 1999; 31: 2175-8.
3. Jeon BH, Kim CS, Kim HS, Park JB, Nam KY, Chang SJ. Effect of Korean red ginseng on blood pressure and nitric oxide production. Acta Pharmacol Sin 2000; 21: 1095-100.
4. Zhan Y, Xu XH, Jiang YP. Protective effects of ginsenoside on myocardiac ischemic and reperfusion injuries. J Natl Med J China 1994; 74: 626-8.
5. Wu JX, Chen JX. Negative chronotropic and inotropic effects of Panax notoginseng saponins. Acta Pharmacol Sin 1988; 9: 409-12.
6. Li XJ, Zhang BH. Studies on anti-arrhythmia effects of panaxatriol saponins isolated from Panax notoginseng. Acta Pharm Sin 1988; 23: 168-73.
7. Zhang RB, Li ZY, Shi HY. Cardiac arrhythmia induced by hypothalamic stimulation in cardiac ischemic rabbits and the antiarrhythmic action of Panax ginseng. Acta Pharmacol Sin 1982; 3: 226-30.
8. + channels and control of ventricular repolarization in the heart. Fundam Clin Pharmacol 1993; 7: 19-28
9. + current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 1990; 96: 195-215.
10. + channel, erg. Circ Res 1997; 80: 261-8.
11. Kr potassium channel. Cell 1995; 81: 299-307.
12. Wang S, Liu S, Morales MJ, Strauss HC, Rasmusson RL. A quantitative analysis of the activation and inactivation kinetics of HERG ex pressed in Xenopus oocytes. J Physiol 1997; 502: 45-60.
13. Kr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 1999; 97: 175-87.
14. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995; 80: 795-803.
15. Suessbrich H, Waldegger S, Lang F, Busch AE. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole. FEBS Lett 1996; 385: 77-80.
16. Rampe D, Roy ML, Dennis A, Brown AM. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG. FEBS Lett 1997; 417: 28-32.
17. Drolet B, Vincent F, Rail J, Chahine M, Deschenes D, Nadeau S, et al. Thioridazine lengthens repolarization of cardiac ventricular myocytes by blocking the delayed rectifier potassium current. J Pharmacol Exp Ther 1999; 288: 1261-8.
18. Volberg WA, Koci BJ, Su W, Lin J, Zhou J. Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics. J Pharmacol Exp Ther 2002; 302: 320-7.
19. Mitcheson JS, Chen J, Lin M, Culberson C, Sanguinetti MC. A structural basis for drug-induced long QT syndrome. Proc Natl Acad Sci USA 2000; 97: 12329-33.
20. Kr: the hERG channel. J Mol Cell Cardiol 2001; 33: 835-49.
21. Bai CX, Sunami A, Namiki T, Sawanobori T, Furukawa T. Electrophysiological effects of ginseng and ginsenoside Re in guinea pig ventricular myocytes. Eur J Pharmacol 2003; 476: 35-44.
22. 2+ current by ginsenoside Re, an ingredient of Panax ginseng, in guinea-pig cardiomyocytes. Br J Pharmacol 2004; 142: 567-75.
23. + channels. J Pharmacol Exp Ther 2002; 302: 314-9.
24. + channel as a target for class III methanesulfonanilides. Circ Res 1995; 77: 1151-5.
25. + channel. Open-channel block by methanesulfonanilides. Circ Res 1996; 78: 499-503.
26. Sanguinetti MC. Dysfunction of delayed rectifier potassium channels in an inherited cardiac arrhythmia. Ann N Y Acad Sci 1999; 868: 406-13.
27. Zhou Z, Gong Q, Epstein ML, January CT. HERG channel dysfunction in human long QT syndrome. Intracellular transport and functional defects. J Biol Chem 1998; 273: 21061-6.
28. + channel activity is regulated by changes in phosphatidyl inositol 4,5-bisphosphate. Circ Res 2001; 89: 1168-76.
29. 2+ mobilization. Br J Pharmacol 2001; 132: 641-8.
30. Choi S, Jung SY, Ko YS, Koh SR, Rhim H, Nah SY. Functional expression of a novel ginsenoside Rf binding protein from rat brain mRNA in Xenopus laevis oocytes. Mol Pharmacol 2002; 61: 928-35.
31. 2+ channels through a pertussis toxin-sensitive G protein. Proc Natl Acad Sci USA 1995; 92: 8739-43.
32. Lawson, K. Potassium channel openers as potential therapeutic weapons in ion channel disease. Kidney Int 2000; 57: 838-45.